Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma

被引：0
|
作者：
Liangsong Zhu
Rong Ding
Jianping Zhang
Jin Zhang
Zongming Lin
机构：
[1] Zhongshan Hospital,Department of Urology
[2] Fudan University,Department of Obstetrics and Gynecology, International Peace Maternity and Child Health Hospital, School of Medicine
[3] Shanghai Jiao Tong University,Department of Urology, Ren Ji Hospital, School of Medicine
[4] Shanghai Jiaotong University,undefined
来源：
BMC Cancer | / 19卷
关键词：
CDK5; p21; ccRCC; Prognostic;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration
    Lampropoulou, Evgenia
    Logoviti, Ioanna
    Koutsioumpa, Marina
    Hatziapostolou, Maria
    Polytarchou, Christos
    Skandalis, Spyros S.
    Hellman, Ulf
    Fousteris, Manolis
    Nikolaropoulos, Sotirios
    Choleva, Efrosini
    Lamprou, Margarita
    Skoura, Angeliki
    Megalooikonomou, Vasileios
    Papadimitriou, Evangelia
    SCIENTIFIC REPORTS, 2018, 8
  • [32] EHD2, a novel HIF target gene, is a promising biomarker in clear cell renal cell carcinoma
    Chen, Yufeng
    Xue, Song
    Shi, Jian
    He, Chunfeng
    Zhang, Qingchuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2023, 16 (11): : 344 - 351
  • [33] Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines
    Akama, Y
    Yasui, W
    Kuniyasu, H
    Yokozaki, H
    Akagi, M
    Tahara, H
    Ishikawa, T
    Tahara, E
    JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (08): : 824 - 830
  • [34] Overexpression of cyclin-dependent kinase 1 in esophageal squamous cell carcinoma and its clinical significance
    Zhang, Han-Jie
    Chen, Gang
    Chen, Shang-Wei
    Fu, Zong-Wang
    Zhou, Hua-Fu
    Feng, Zhen-Bo
    Mo, Jun-Xian
    Li, Chang-Bo
    Liu, Jun
    FEBS OPEN BIO, 2021, 11 (11): : 3126 - 3141
  • [35] Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation
    Xing, Chunyang
    Xie, Haiyang
    Zhou, Lin
    Zhou, Wuhua
    Zhang, Wu
    Ding, Songming
    Wei, Bajin
    Yu, Xiaobo
    Su, Rong
    Zheng, Shusen
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 420 (01) : 29 - 35
  • [36] Clinical and biological impact of cyclin-dependent kinase subunit 2 in esophageal squamous cell carcinoma
    Kita, Yoshiaki
    Nishizono, Yuka
    Okumura, Hiroshi
    Uchikado, Yasuto
    Sasaki, Ken
    Matsumoto, Masataka
    Setoyama, Tetsuro
    Tanoue, Kiyonori
    Omoto, Itaru
    Mori, Shinichiro
    Owaki, Tetsuhiro
    Ishigami, Sumiya
    Nakagawa, Hiroshi
    Tanaka, Fumiaki
    Mimori, Koshi
    Mori, Masaki
    Natsugoe, Shoji
    ONCOLOGY REPORTS, 2014, 31 (05) : 1986 - 1992
  • [37] Extraneuronal roles of cyclin-dependent kinase 5
    Rosales, Jesusa L.
    Lee, Ki-Young
    BIOESSAYS, 2006, 28 (10) : 1023 - 1034
  • [38] Cyclin-dependent kinase-5 in neurodegeneration
    Shelton, SB
    Johnson, GVW
    JOURNAL OF NEUROCHEMISTRY, 2004, 88 (06) : 1313 - 1326
  • [39] The role of cyclin-dependent kinase inhibitor p27 in squamous cell carcinoma of the esophagus
    Shibata, H
    Matsubara, O
    Wakiyama, H
    Tanaka, S
    PATHOLOGY RESEARCH AND PRACTICE, 2001, 197 (03) : 157 - 164
  • [40] The effect of R547, a cyclin-dependent kinase inhibitor, on hepatocellular carcinoma cell death
    Hacioglu, Betul
    Kus, Gokhan
    Kutlu, Hatice Mehtap
    Kabadere, Selda
    TURKISH JOURNAL OF BIOLOGY, 2020, 44 (01) : 24 - 33
12345